Lamivudine/tenofovir
Lamivudine/tenofovir disoproxil, sold under the brand name Cimduo among others, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS in adults and children weighing more than 35 kilograms (77 lb). It contains lamivudine and tenofovir disoproxil. It is taken by mouth.Lamivudine/tenofovir was approved for medical use in the United States in February 2018.

References
Further reading
"WHO Public Assessment Report: HA414 - Lamivudine/Tenofovir disoproxil fumarate - 300mg/300mg - Tablets - Mylan Laboratories Ltd - India". World Health Organization (WHO). Archived from the original on 26 March 2020.

External links
"Lamivudine". Drug Information Portal. U.S. National Library of Medicine.
"Tenofovir disoproxil". Drug Information Portal. U.S. National Library of Medicine.
"Tenofovir disoproxil fumarate". Drug Information Portal. U.S. National Library of Medicine.